Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1989 | 12-1988 | |
| Sales | 20,925 | 20,925 |
| Cost of Goods | 13,128 | 13,128 |
| Gross Profit | 7,797 | 7,797 |
| Operating Expenses | 5,832 | 5,832 |
| Operating Income | 2,093 | 2,093 |
| Interest Expense | 634 | 634 |
| Other Income | 317 | 317 |
| Pre-tax Income | 1,775 | 1,775 |
| Income Tax | 517 | 517 |
| Net Income Continuous | 1,259 | 1,259 |
| Net Income | $1,259 | $1,259 |
| EPS Basic Total Ops | 0.05 | 0.05 |
| EPS Basic Continuous Ops | 0.05 | 0.05 |
| EPS Diluted Total Ops | 0.05 | 0.05 |
| EPS Diluted Continuous Ops | 0.05 | 0.05 |
| EBITDA(a) | $2,796 | $2,796 |